Precision pathology analysis of the development and progression of hepatocellular carcinoma: Implication for precision diagnosis of hepatocellular carcinoma. Issue 3 (6th January 2020)
- Record Type:
- Journal Article
- Title:
- Precision pathology analysis of the development and progression of hepatocellular carcinoma: Implication for precision diagnosis of hepatocellular carcinoma. Issue 3 (6th January 2020)
- Main Title:
- Precision pathology analysis of the development and progression of hepatocellular carcinoma: Implication for precision diagnosis of hepatocellular carcinoma
- Authors:
- Ueno, Akihisa
Masugi, Yohei
Yamazaki, Ken
Kurebayashi, Yutaka
Tsujikawa, Hanako
Effendi, Kathryn
Ojima, Hidenori
Sakamoto, Michiie - Abstract:
- Abstract : Outcomes for patients with hepatocellular carcinoma (HCC) remain poor because the condition is often unresponsive to the available treatments. Consequently, the early and precise diagnosis of HCC is crucial to achieve improvements in prognosis. For patients with chronic liver disease, the assessment of liver fibrosis is also important to ascertain both the staging of fibrosis and the risk of HCC occurrence. Early HCC was first described in 1991 in Japan and was defined internationally in 2009. As the concept of early HCC spread, the multistage hepatocarcinogenesis process became accepted. Consequently, improvements in imaging technology made the early diagnosis of HCC possible. At present, the most appropriate therapeutic strategy for HCC is determined using an integrated staging system that assesses the tumor burden, the degree of liver dysfunction and the patient performance status; however, pathological and molecular features are not taken into account. The recent introduction of several new therapeutic agents will change the treatment strategy for HCC. Against this background, HCC subclassification based on tumor cellular and microenvironmental characteristics will become increasingly important. In this review, we give an overview of how pathological analysis contributes to understanding the development and progression of HCC and establishing a precision diagnosis of HCC.
- Is Part Of:
- Pathology international. Volume 70:Issue 3(2020)
- Journal:
- Pathology international
- Issue:
- Volume 70:Issue 3(2020)
- Issue Display:
- Volume 70, Issue 3 (2020)
- Year:
- 2020
- Volume:
- 70
- Issue:
- 3
- Issue Sort Value:
- 2020-0070-0003-0000
- Page Start:
- 140
- Page End:
- 154
- Publication Date:
- 2020-01-06
- Subjects:
- computational pathology -- early HCC -- fibrous stroma -- HCC -- immune microenvironment -- molecular diagnosis -- molecular marker -- molecular subclass -- multistage hepatocarcinogenesis -- patho‐radiological correlation
Pathology -- Periodicals
616.07 - Journal URLs:
- http://www.blackwell-synergy.com/member/institutions/issuelist.asp?journal=pin ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1111/pin.12895 ↗
- Languages:
- English
- ISSNs:
- 1320-5463
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6412.823000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 24532.xml